| 191 |
APELIDX |
ALPELISIB 50 MG |
FILM COATED TABLET |
BOTTLE |
IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF POSTMENOPAUSUAL WOMEN, AND MEN WITH HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE, PIK3CA MUTED, ADVANCED OR METASTATIC BREAST CANCER. |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1331/25 |
27-MAY-2025 |
26-MAY-2030 |
View |
| 192 |
APELIDX |
ALPELISIB 50 MG |
FILM COATED TABLET |
BOTTLE |
IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF POSTMENOPAUSUAL WOMEN, AND MEN WITH HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE, PIK3CA MUTED, ADVANCED OR METASTATIC BREAST CANCER. |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 1331/25 |
27-MAY-2025 |
26-MAY-2030 |
View |
| 193 |
BETALOL 40 MG |
PROPRANOLOL HCL 40 MG |
FILM-COATED TABLETS |
ALU-PVC BLISTERPACK |
HYPERTENSION, ANGINA PECTORIS, PHEOCHROMOCYTOMA, ESSENTIAL TREMOR, PREVENTION OF MYOCARDIAL INFRACTION, SUPRAVENTRICULAR ARRHYTHMIAS, VENTRICULAR TACHYCARDIAS. |
NULL |
BERLIN PHARMA LAO CO.,LTD |
BERLIN PHARMACEUTICAL INDUSTRY CO., LTD. |
THAILAND |
STEP 1: RECEIVE (RENEW) |
03 I 3528/11 |
23-AUG-2022 |
22-AUG-2025 |
View |
| 194 |
ASIDX |
AXITINIB 5 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA AFTER FAILURE OF ONE PRIOR SYSTEMIC THERAPY |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1204/24 |
03-OCT-2024 |
02-OCT-2029 |
View |
| 195 |
AVATODX |
AVATROMBOPAG 20 MG |
TABLET |
BOTTLE |
TREATMENT OF THROMBOCYTOPENIA IN ADULT |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 0985/23 |
04-JUL-2023 |
03-JUL-2026 |
View |
| 196 |
BARUDX |
BARICITINIB 2 MG |
FILM COATED TABLET |
BOTTLE |
TO TREAT RHEUMATOID ARTHRITIS (CONDITION IN WHICH THE BODY ATTACKS ITS OWN JOINTS CAUSING PAIN, SWELLING, AND LOSS OF FUNCTION) IN ADULT WHO HAVE NOT RESPONDED WELL TO ONBE OR MORE TUMOR NECROSIS FACTOR INHOBITOR MEDICATION. |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1083/24 |
29-MAR-2024 |
28-MAR-2027 |
View |
| 197 |
BARUDX |
BARICITINIB 4 MG |
FILM COATED TABLET |
BOTTLE |
TO TREAT RHEUMATOID ARTHRITIS (CONDITION IN WHICH THE BODY ATTACKS ITS OWN JOINTS CAUSING PAIN, SWELLING, AND LOSS OF FUNCTION) IN ADULT WHO HAVE NOT RESPONDED WELL TO ONBE OR MORE TUMOR NECROSIS FACTOR INHOBITOR MEDICATION. |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1084/24 |
29-MAR-2024 |
28-MAR-2027 |
View |
| 198 |
BEDADX |
BEDAQUILINE 100 MG |
TABLET |
BOTTLE |
INDICATES AS PART OF COMBINATION THERAPY IN ADULT (>=18YEARS) WITH PULMONARY MULTI-DRUG RESISTANT TUBERCULOSIS (MDR-TB) |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
11 L 1244/24 |
03-DEC-2024 |
02-DEC-2029 |
View |
| 199 |
BEIDUDX |
BELUMOSUDIL 200 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT AND PEDIATRIC PATIENTS 12 YEARS AND OLDER WITH CHRONIC GRAFT-VERSUS-HOST DISEASE (CHRONIC GVHD) AFTER FAILURE OF AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1332/25 |
2025-04-21 |
2030-04-20 |
View |
| 200 |
BESIDX |
ABEMACICLIB 150 MG |
FILM COATED TABLET |
BOTTLE |
TO TREAT CERTAIN TYPE OF HORMONE RECEPTOR POSITIVE, EARLY BREAST CANCER OR BREAST CANCER THAT HAS SPREAD TO OTHER PARTSOF THE BODY AFTER TREATMENT WITH AN ANTIESTROGEN MEDICATION SUCH AS TAMOXIFEN |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1097/24 |
06-MAY-2024 |
05-MAY-2027 |
View |
